NutriBand R&D Spending Growth & History (NTRB)
NutriBand's r&d spending was $1.9M for fiscal 2026.
View full NutriBand company overviewNutriBand annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | $1.9M | −$1.2M | −39.37% |
| 2025 | 2025-01-31 | $3.1M | $1.2M | +59.10% |
| 2024 | 2024-01-31 | $2.0M | $978,198 | +99.59% |
| 2023 | 2023-01-31 | $982,227 | $570,844 | +138.76% |
| 2022 | 2022-01-31 | $411,383 | — | — |
NutriBand quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2027 | 2026-07-31 | $322,194 | −$240,360 | −42.73% |
| Q1 2027 | 2026-04-30 | $247,261 | −$436,165 | −63.82% |
| Q4 2026 | 2026-01-31 | $188,036 | −$301,820 | −61.61% |
| Q3 2026 | 2025-10-31 | $457,113 | −$423,655 | −48.10% |
| Q2 2026 | 2025-07-31 | $562,554 | −$211,421 | −27.32% |
| Q1 2026 | 2025-04-30 | $683,426 | −$291,109 | −29.87% |
| Q4 2025 | 2025-01-31 | $489,856 | −$73,514 | −13.05% |
| Q3 2025 | 2024-10-31 | $880,768 | $329,265 | +59.70% |
| Q2 2025 | 2024-07-31 | $773,975 | $328,853 | +73.88% |
| Q1 2025 | 2024-04-30 | $974,535 | $574,105 | +143.37% |
| Q4 2024 | 2024-01-31 | $563,370 | $267,544 | +90.44% |
| Q3 2024 | 2023-10-31 | $551,503 | $260,785 | +89.70% |
| Q2 2024 | 2023-07-31 | $445,122 | $167,253 | +60.19% |
| Q1 2024 | 2023-04-30 | $400,430 | $282,616 | +239.88% |
| Q4 2023 | 2023-01-31 | $295,826 | — | — |
| Q3 2023 | 2022-10-31 | $290,718 | $129,718 | +80.57% |
| Q2 2023 | 2022-07-31 | $277,869 | — | — |
| Q1 2023 | 2022-04-30 | $117,814 | — | — |
| Q3 2022 | 2021-10-31 | $161,000 | — | — |
NutriBand r&d spending trends
Between the periods ended 2022-01-31 and 2026-01-31, NutriBand's r&d spending increased from $411,383 to $1.9M, a change of $1.5M. The latest reported quarter, Q2 2027, shows $322,194.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NutriBand source filings ↗